Skip to search formSkip to main contentSkip to account menu

DC 159a

Known as: DC-159a, DC159a 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Chondrotoxicity and toxicokinetics of novel quinolone antibacterial agents DC-159a and DX-619 in juvenile rats.
2008
2008
Antimicrobial Activity of DC-159a, a New Fluoroquinolone, against 1,149 Recently Collected Clinical Isolates
ABSTRACT The activity of DC-159a, a novel orally administered fluorinated quinolone, was evaluated by reference broth… 
2007
2007
In Vitro Activity of DC-159a, a New Broad-Spectrum Fluoroquinolone, Compared with That of Other Agents against Drug-Susceptible and -Resistant Pneumococci
ABSTRACT DC-159a yielded MICs of ≤1 μg/ml against 316 strains of both quinolone-susceptible and -resistant pneumococci… 
2006
2006
In Vivo Efficacy of DC-159 a , a New Generation of Respiratory Quinolone , against Experimental Murine Tuberculosis due to Multi-Drug-Resistant Mycobacterium tuberculosis
N H2 OMe Me 1/2 H2O The concentration and lung/serum ratio of DC-159a in CBA/JNCrlj mice were higher than those of MFLX, LVFX and… 
2006
2006
Interscience conference on antimicrobial agents and chemotherapy--46th annual meeting. Release of data for Dc-159a, and other agents. 27-30 September 2006, San Francisco, CA, USA.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)